Hypermethylation reduces the expression of PNPLA7 in hepatocellular carcinoma
Author(s) -
Xiaojiao Zhang,
Jun Zhang,
Rui Wang,
Shicheng Guo,
Huilu Zhang,
Yanyun Ma,
Qingmei Liu,
Haiyan Chu,
Xianghong Xu,
Yitong Zhang,
Dongqin Yang,
Jiucun Wang,
Jie Liu
Publication year - 2016
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2016.4660
Subject(s) - dna methylation , oncogene , hepatocellular carcinoma , liver cancer , cancer , methylation , biology , molecular medicine , cancer research , phospholipase a2 , gene silencing , lipid metabolism , cell cycle , cancer cell , gene expression , endocrinology , enzyme , biochemistry , genetics , gene
Liver cancer has a high morbidity and mortality rate, and is one of the most common types of cancer in men. PNPLA7 is a member of the patatin-like phospholipase domain-containing protein family which is involved in triglyceride hydrolysis, energy metabolism and lipid droplet metabolism. The liver is the most important energy metabolism organ; whether PNPLA7 is deregulated in liver cancer has not been previously reported. In the present study, reverse transcription-quantitative polymerase chain reaction and subsequent methylation analysis provided evidence that PNPLA7 is down-regulated in hepatocellular carcinoma (HCC) cell lines and tissue samples, via the mechanism of transcriptional silencing by promoter hypermethylation. These results may provide novel insights for HCC diagnosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom